The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis

International Journal of Environmental Research and Public Health

Karen Eggleston²  Ruifang Zhang¹ 

[1] Global Investment Research, Goldman Sachs International, Peterborough Court, 133 Fleet Street, London EC4A 2BB, UK; E-Mail:;Shorenstein Asia-Pacific Research Center, Stanford University, 616 Serra Road, Encina Hall, Stanford, CA 94305, USA

关键词: antimicrobial resistance;    economic analysis;    drug resistance;    behavioral economics;   

DOI  :  10.3390/ijerph7083141

来源: mdpi

【 摘 要 】

The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention. Like an environmental resource, antimicrobials require stewardship. The effectiveness of an antimicrobial agent is a global public good. We argue for greater use of economic analysis as an input to policy discussion about AR, including for understanding the incentives underlying health behaviors that spawn AR, and to supplement other methods of tracing the evolution of AR internationally. We also discuss integrating antimicrobial stewardship into global health governance.

【 授权许可】

CC BY   
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.